Showing results (591-600 of 4,043) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|December 30, 2008
Estrogens and the risk of complex regional pain syndrome (CRPS)M de Mos, F J P M Huygen, B H Ch Stricker, et al.Pharmacoepidemiology and Drug Safety|December 31, 2008
Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?Yan Chen, Jeff J Guo, Nick C PatelPharmacoepidemiology and Drug Safety|January 1, 2009
Emergency department visits attributed to selected analgesics, United States, 2004-2005Mary Willy, Judith P Kelly, Parivash Nourjah, et al.Pharmacoepidemiology and Drug Safety|January 17, 2009
Antidepressant medication use and risk of persistent pulmonary hypertension of the newbornSusan E Andrade, Heather McPhillips, David Loren, et al.Pharmacoepidemiology and Drug Safety|October 12, 2007
Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement ratesAnnemiek E Akkerman, Marijke M Kuyvenhoven, Theo J M Verheij, et al.Pharmacoepidemiology and Drug Safety|October 24, 2007
Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatricsKitio Brice, Bertholle Valerie, Galambrun Claire, et al.Pharmacoepidemiology and Drug Safety|October 27, 2007
Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawalMyrthe P P Sukel, Michiel W van der Linden, Connie Chen, et al.Pharmacoepidemiology and Drug Safety|July 10, 2008
Syncope and sinus bradycardia from combined use of thalidomide and beta-blockerTakashi YamaguchiPharmacoepidemiology and Drug Safety|August 14, 2008
Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel useR Ostini, D Hegney, J M Mackson, et al.Pharmacoepidemiology and Drug Safety|September 26, 2008
Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease modelA Villaverde-Hueso, M Posada de la Paz, M C Martín-Arribas, et al.Pageof 405